Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. 2002

Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
Department of Oncology, Osaka University Graduate School of Medicine, 2-2, Yamada-oka, Suita, Osaka 565-0871, Japan.

IL-12 and IL-18 synergistically enhance IFN-gamma mRNA transcription by activating STAT4 and AP-1, respectively. However, it is still unknown how STAT4/AP-1 elicit IFN-gamma promoter activation. Using an IL-12/IL-18-responsive T cell clone, we investigated the mechanisms underlying synergistic enhancement of IFN-gamma mRNA expression induced by these two cytokines. Synergy was observed in a reporter gene assay using an IFN-gamma promoter fragment that binds AP-1, but not STAT4. An increase in c-Jun, a component of AP-1, in the nuclear compartment was elicited by stimulation with either IL-12 or IL-18, but accumulation of serine-phosphorylated c-Jun was induced only by IL-18 capable of activating c-Jun N-terminal kinase. The binding of AP-1 to the relevant promoter sequence depended on the presence of STAT4. STAT4 bound with c-Jun, and a phosphorylated c-Jun-STAT4 complex most efficiently interacted with the AP-1-relevant promoter sequence. Enhanced cobinding of STAT4 and c-Jun to the AP-1 sequence was also observed when activated lymph node T cells were exposed to IL-12 plus IL-18. These results show that STAT4 up-regulates AP-1-mediated IFN-gamma promoter activation without directly binding to the promoter sequence, providing a mechanistic explanation for IL-12/IL-18-induced synergistic enhancement of IFN-gamma gene expression.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
September 2000, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
July 2001, European journal of immunology,
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
December 2002, Proceedings of the National Academy of Sciences of the United States of America,
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
March 2002, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
August 1999, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
May 1999, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
March 2001, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
December 2001, Journal of immunology (Baltimore, Md. : 1950),
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
December 2008, Journal of ethnopharmacology,
Masakiyo Nakahira, and Hyun-Jong Ahn, and Woong-Ryeon Park, and Ping Gao, and Michio Tomura, and Cheung-Seog Park, and Toshiyuki Hamaoka, and Tsunetaka Ohta, and Masashi Kurimoto, and Hiromi Fujiwara
August 2017, Molecular immunology,
Copied contents to your clipboard!